Earnings Feed
Start Free
EyePoint Pharmaceuticals, Inc.·4

Feb 11, 4:54 PM ET

Landis John B. 4

4 · EyePoint Pharmaceuticals, Inc. · Filed Feb 11, 2022

Insider Transaction Report

Form 4
Period: 2022-02-09
EyePoint Pharmaceuticals, Inc.EYPT
Landis John B.
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2022-02-09+2,500→ 8,400 total
  • Exercise/Conversion

    Restricted Stock Units

    2022-02-09−2,500→ 0 total
    Exercise: $0.00→ Common Stock (2,500 underlying)
  • Award

    Restricted Stock Units

    2022-02-09+3,000→ 3,000 total
    Exercise: $0.00→ Common Stock (3,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2022-02-09+11,000→ 11,000 total
    Exercise: $10.13From: 2023-02-09Exp: 2032-02-09→ Common Stock (11,000 underlying)
Footnotes (2)
  • [F1]Fully vested on the one-year anniversary of the grant date.
  • [F2]Will fully vest on the one-year anniversary of the grant date.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT